Investigating How Tissue Level Targeting Affects Biodistribution of Ingestible Injectables
Time: 1:15 pm
day: Day One
Details:
• Biodistribution pathways when administering to the stomach rather than subcutaneous
• Biodistribution over tissue layers
• LUMI device system for insulin delivery
